Bendamustine plus thalidomide and dexamethasone may be a viable salvage option for the treatment of double-relapsed/refractory multiple myeloma.
Adjusting the starting dose of lenalidomide according to renal function did not compromise the efficacy or safety of lenalidomide.
Early initiation of concurrent palliative oncology care improved 1-year survival compared with delayed initiation.
A biomarker panel was shown to be a surrogate for survival in patients with metastatic castration-resistant prostate cancer (mCRPC).
Intraperitoneal (IP) as opposed to intravenous (IV) chemotherapy is associated with better survival in patients with advanced ovarian cancer.
There is a considerable gap between patient expectations and current practices for information relating to radiation use.
For non-small-cell lung cancer (NSCLC), pulmonologist management is positively associated with rates of stage-specific treatment.
Nivolumab may be safe and effective in patients with advanced treatment-refractory renal cell carcinoma (RCC).
HER2-specific T cells can persist for 6 weeks without evident toxicities in patients with HER2-positive sarcoma.
Cognitive-behavioral stress management (CBSM) delivered after breast cancer surgery is associated with long-term psychological benefits.
Nivolumab led to a greater proportion of patients with advanced melanoma achieving an objective response and with fewer adverse events.
Doxorubicin plus trabectedin have activity as first-line treatment for uterine leiomyosarcoma and soft-tissue leiomyosarcoma.
Addition of ganitumab to gemcitabine did not improve overall survival in unselected patients with metastatic pancreatic cancer.
Linsitinib did not improve overall survival in patients with locally advanced or metastatic adrenocortical carcinoma.
No continuation of bevacizumab after first-line chemotherapy in metastatic colorectal cancer is not non-inferior to continuation.
Minority patients are less actively involved in surgeon and hospital selection for breast cancer surgery.
The incidence of non-melanoma skin cancer (NMSC) is much higher for Caucasians than Hispanics or Asians.
For patients with head and neck cancer, smoking and alcohol consumption predict gastrostomy tube (GT) insertion use.
Abiraterone acetate administered with food may help to reverse PSA progression in metastatic castration-resistant prostate cancer (mCRPC).
Acute toxicity rate is high in elderly head and neck squamous cell carcinoma patients undergoing chemotherapy and radiation therapy.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Urine Test for Kidney Cancer Showing Promise
- BTD Regimen May Be Viable Salvage Option for Multiple Myeloma
- Adjusting Starting Dose of Lenalidomide for Renal Function May Not Compromise Efficacy
- Early Initiation of Palliative Care Improves 1-Year Survival
- Biomarker Panel Shown to Be Surrogate for Survival in Prostate Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|